Dose-response Enteral Citrulline for Normal Healthy Volunteers and Surgery Patients
Primary Purpose
Nutritional Deficiency
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
citrulline
Lemonade
Sponsored by
About this trial
This is an interventional supportive care trial for Nutritional Deficiency
Eligibility Criteria
Inclusion Criteria:
- adults, male & female, non-pregnant
- BMI 18.5-29.9
Exclusion Criteria:
- cancer
- HIV positive
Sites / Locations
- University of Pittsburgh Medical Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Citrulline
lemonade
Arm Description
Equal volume and flavor to citrulline.
Outcomes
Primary Outcome Measures
Plasma amino acid levels
Secondary Outcome Measures
Full Information
NCT ID
NCT00950976
First Posted
July 10, 2009
Last Updated
April 24, 2012
Sponsor
Société des Produits Nestlé (SPN)
1. Study Identification
Unique Protocol Identification Number
NCT00950976
Brief Title
Dose-response Enteral Citrulline for Normal Healthy Volunteers and Surgery Patients
Official Title
Clinical Trial of Enteral Citrulline in Volunteers With Surgical Repair of Ventral Hernias
Study Type
Interventional
2. Study Status
Record Verification Date
April 2012
Overall Recruitment Status
Completed
Study Start Date
March 2008 (undefined)
Primary Completion Date
April 2010 (Actual)
Study Completion Date
August 2010 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Société des Produits Nestlé (SPN)
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
To determine the level of citrulline to produce a given amount of arginine in healthy volunteers and surgical patients. Arginine-related amino acids are expected to increase as a result of increased substrate provided by citrulline.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Nutritional Deficiency
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
14 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Citrulline
Arm Type
Experimental
Arm Title
lemonade
Arm Type
Placebo Comparator
Arm Description
Equal volume and flavor to citrulline.
Intervention Type
Other
Intervention Name(s)
citrulline
Intervention Description
TID for 5 days
Intervention Type
Other
Intervention Name(s)
Lemonade
Intervention Description
TID for 5 days
Primary Outcome Measure Information:
Title
Plasma amino acid levels
Time Frame
8 hours
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
adults, male & female, non-pregnant
BMI 18.5-29.9
Exclusion Criteria:
cancer
HIV positive
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Juan B. Ochoa, MD Prof.
Organizational Affiliation
Associate Professor of Surgery and Critical Care, University of Pittsburgh Physicians
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Pittsburgh Medical Center
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15213
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Dose-response Enteral Citrulline for Normal Healthy Volunteers and Surgery Patients
We'll reach out to this number within 24 hrs